MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,787 | -43.8% | 555,392 | -5.8% | 0.00% | -50.0% |
| Q2 2023 | $282,371 | -28.0% | 589,500 | -2.3% | 0.00% | -20.0% |
| Q1 2023 | $392,215 | +54.8% | 603,407 | +11.9% | 0.01% | +25.0% |
| Q4 2022 | $253,354 | -43.4% | 539,051 | -50.0% | 0.00% | -20.0% |
| Q3 2022 | $447,447 | -29.1% | 1,078,102 | +100.0% | 0.01% | -58.3% |
| Q2 2022 | $631,000 | -7.9% | 539,051 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $685,000 | -22.1% | 539,051 | 0.0% | 0.01% | +33.3% |
| Q4 2021 | $879,000 | -41.1% | 539,051 | 0.0% | 0.01% | -53.8% |
| Q3 2021 | $1,493,000 | -8.0% | 539,051 | 0.0% | 0.01% | -13.3% |
| Q2 2021 | $1,623,000 | -26.2% | 539,051 | 0.0% | 0.02% | -40.0% |
| Q1 2021 | $2,199,000 | -12.9% | 539,051 | -0.1% | 0.02% | +13.6% |
| Q4 2020 | $2,526,000 | – | 539,651 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 350,000 | $1,054,000 | 0.54% |
| AIGH Capital Management LLC | 915,000 | $2,768,000 | 0.50% |
| AWM Investment Company, Inc. | 1,000,000 | $3,017,000 | 0.30% |
| Board of Trustees of The Leland Stanford Junior University | 962,932 | $2,898,000 | 0.27% |
| Worth Venture Partners, LLC | 215,030 | $647,000 | 0.24% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 110,515 | $333,000 | 0.15% |
| INTACT INVESTMENT MANAGEMENT INC. | 385,600 | $1,427,000 | 0.04% |
| Verition Fund Management LLC | 539,051 | $1,623,000 | 0.02% |
| Patriot Financial Group Insurance Agency, LLC | 22,900 | $69,000 | 0.01% |
| Maven Securities LTD | 79,118 | $234,000 | 0.01% |